RHI
52
2
MMM
50
-2
DHR
56
-4
EFX
69
-6
TROW
34
2
VRTX
60
-3
KIM
51
-3
EXPD
54
7
SYK
59
-5
MET
51
4
PSA
66
-2
PFE
33
-2
MCHP
47
-2
TGNA
48
5
HST
52
3
AAL
50
8
RCL
72
-2
SLB
50
4
MRO
50
3
UHS
54
-4
RHI
52
2
MMM
50
-2
DHR
56
-4
EFX
69
-6
TROW
34
2
VRTX
60
-3
KIM
51
-3
EXPD
54
7
SYK
59
-5
MET
51
4
PSA
66
-2
PFE
33
-2
MCHP
47
-2
TGNA
48
5
HST
52
3
AAL
50
8
RCL
72
-2
SLB
50
4
MRO
50
3
UHS
54
-4
Financhill
Back

Predictive Oncology Vs. Perspective Therapeutics Industry Stock Comparison

Sell
39

POAI
Predictive Oncology

Last Price:
0.90
Seasonality Move:
-7.5%
Sell
30

CATX
Perspective Therapeutics

Last Price:
13.38
Seasonality Move:
-10.19%
Sell
39
Predictive Oncology (POAI) is a Sell

Is Predictive Oncology a Buy, Sell or Hold?

  • The current Predictive Oncology [POAI] share price is $0.92. The Score for POAI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • POAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.32. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

POAI Stock Price Chart

What is Predictive Oncology's stock price today?

  • The Predictive Oncology share price today is $0.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and POAI is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

POAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 11926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.89 - 0.95) Sell
Bollinger Bands (100): (0.91 - 1.53) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 41.66 Sell
Chaikin Money Flow: 400659 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.87 - 15.77) Sell
Bollinger Bands (100): (11.56 - 16.02) Sell

POAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Sell
20-day SMA: 0.93 Sell
50-day SMA: 1.02 Sell
200-day SMA: 2 Sell
8-day EMA: 0.92 Sell
20-day EMA: 0.93 Sell
50-day EMA: 1.03 Sell
200-day EMA: 2 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.97 Sell
20-day SMA: 15.14 Sell
50-day SMA: 13.64 Sell
200-day SMA: 11.16 Buy
8-day EMA: 14.56 Sell
20-day EMA: 14.66 Sell
50-day EMA: 14 Sell
200-day EMA: 11.47 Buy

Predictive Oncology Earnings Growth & POAI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Predictive Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):